Obstructive Sleep Apnea Care Pathways: Clinical Summary
A concise clinical summary addressing key learning objectives for translating cardiometabolic risk into longitudinal OSA management.
This program is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals globally excluding the UK.
Bidirectional Pathophysiology: Dr. Somers
- Obstructive sleep apnea (OSA) drives cardiometabolic risk through hypoxia, hypercapnia, and sleep disruption, leading to sympathetic activation, systemic inflammation, and oxidative stress.
- These physiological disruptions result in insulin resistance and blood pressure surges, presenting clinically as prediabetes, type 2 diabetes, and hypertension.
- The relationship is a bidirectional loop: obesity causes OSA via mechanical loading on the airway, while OSA exacerbates obesity by triggering sleep disruptions that increase somnolence and food intake.